HIGHLIGHTS
- who: Gaber El-Saber Batiha from the Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira, Egypt have published the research: Potential role of lipoxin in the management of COVID-19: a narrative review, in the Journal: (JOURNAL)
- what: As LXs are potent anti-inflammatory mediators, the authors aimed at reviewing the potential role of LXs in COVID-19 regarding the effects of LXs on the inflammatory signaling pathways which are linked with COVID-19 pathogenesis. This study had several limitations including a paucity of preclinical_trials and prospective clinical studies regarding . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.